Biologics and generics reported to save NHS £700m
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.
List view / Grid view
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.
A statement from 11 health union leaders highlights the possibility of severe drug shortages if the UK leaves the EU without a deal.
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.
The NHS is set to launch a new payment method for antibiotic development to incentivise pharmaceutical companies.
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.